Bristol-Myers Squibb Aktie

Kaufen
Verkaufen
55,17 EUR +0,93 EUR +1,71 %
57,33 USD -0,24 USD -0,42 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 112,37 Mrd. EUR

KGV 13,29 Div. Rendite 4,50%

WKN 850501

ISIN US1101221083

Symbol BMY


Bristol-Myers Squibb Aktie Analyse

15.04.11 Bristol-Myers Squibb overweight Barclays Capital
07.04.11 Bristol-Myers Squibb overweight Barclays Capital
31.03.11 Bristol-Myers Squibb hold Jefferies & Company Inc.
29.03.11 Bristol-Myers Squibb overweight Barclays Capital
29.03.11 Bristol-Myers Squibb buy Goldman Sachs Group Inc.
28.03.11 Bristol-Myers Squibb neutral Credit Suisse Group
22.03.11 Bristol-Myers Squibb neutral Credit Suisse Group
31.01.11 Bristol-Myers Squibb overweight Barclays Capital
10.01.11 Bristol-Myers Squibb buy Citigroup Corp.
22.11.10 Bristol-Myers Squibb overweight Barclays Capital
28.10.10 Bristol-Myers Squibb overweight Barclays Capital
21.10.10 Bristol-Myers Squibb overweight Barclays Capital
05.10.10 Bristol-Myers Squibb equal-weight Morgan Stanley
09.09.10 Bristol-Myers Squibb overweight Barclays Capital
01.09.10 Bristol-Myers Squibb neutral UBS AG
31.08.10 Bristol-Myers Squibb buy Jefferies & Company Inc.
27.07.10 Bristol-Myers Squibb overweight Barclays Capital
16.07.10 Bristol-Myers Squibb kaufen Barclays Capital
30.04.10 Bristol-Myers Squibb kaufen Barclays Capital
30.04.10 Bristol-Myers Squibb halten Credit Suisse Group
15.04.10 Bristol-Myers Squibb kaufen Barclays Capital
13.04.10 Bristol-Myers Squibb halten Goldman Sachs Group Inc.
05.03.10 Bristol-Myers Squibb kaufen Morgan Stanley
16.12.09 Bristol-Myers Squibb neutral UBS AG
07.12.09 Bristol-Myers Squibb neutral Credit Suisse Group
28.10.09 Bristol-Myers Squibb overweight Barclays Capital
26.10.09 Bristol-Myers Squibb neutral Goldman Sachs Group Inc.
12.10.09 Bristol-Myers Squibb neutral Cowen and Company, LLC
31.08.09 Bristol-Myers Squibb equal-weight Morgan Stanley
24.07.09 Bristol-Myers Squibb neutral Credit Suisse Group
24.07.09 Bristol-Myers Squibb neutral Credit Suisse Group
16.07.09 Bristol-Myers Squibb overweight Morgan Stanley
01.06.09 Bristol-Myers Squibb buy UBS AG
07.05.09 Bristol-Myers Squibb Focus Money
03.04.09 Bristol-Myers Squibb market perform Sanford C. Bernstein and Co., Inc.
02.04.09 Bristol-Myers Squibb buy UBS AG
09.02.09 Bristol-Myers Squibb Wirtschaftswoche
17.12.08 Bristol-Myers Squibb neutral Merrill Lynch & Co., Inc.
11.12.08 Bristol-Myers Squibb buy Citigroup Corp.
08.12.08 Bristol-Myers Squibb Wirtschaftswoche
17.11.08 Bristol-Myers Squibb neutral Banc of America Securities LLC
24.09.08 Bristol-Myers Squibb buy UBS AG
12.09.08 Bristol-Myers Squibb buy UBS AG
28.08.08 Bristol-Myers Squibb overweight Lehman Brothers Inc.
18.07.08 Bristol-Myers Squibb hold Citigroup Corp.
30.06.08 Bristol-Myers Squibb outperform Sanford C. Bernstein and Co., Inc.
25.06.08 Bristol-Myers Squibb neutral JP Morgan Chase & Co.
06.06.08 Bristol-Myers Squibb market perform Rodman & Renshaw, LLC
04.06.08 Bristol-Myers Squibb neutral Cowen and Company, LLC
02.06.08 Bristol-Myers Squibb buy UBS AG